WASHINGTON (AP) -- Federal health officials are alerting asthma patients that a type of inhaler sold over the counter will be phased out at year's end because it uses carbon gas that depletes the Earth's atmosphere.
The Food and Drug Administration says patients who use the epinephrine inhalers will need to switch to other types of inhalers which are only available with a doctor's prescription. The Epinephrine inhalers subject to the ban use chlorofluorocarbons to propel medication into the patient's airways.
The FDA finalized plans to phase out the products in 2008 and currently only Armstrong Pharmaceutical's Primatene mist is still available in the U.S. Other manufacturers have switched to an environmentally-friendly propellant called hydrofluoroalkane. These inhalers treat the same asthma symptoms but are only available via prescription.
(Copyright 2011 by The Associated Press. All Rights Reserved.)
To comment, the following rules must be followed:
Comments may be monitored for inappropriate content, but the station is under no legal obligation to do so.
If you believe a comment violates the above rules, please use the Flagging Tool to alert a Moderator.
Flagging does not guarantee removal.
Multiple violations may result in account suspension.
Decisions to suspend or unsuspend accounts are made by Station Moderators.
Links require admin approval before posting.
Questions may be sent to email@example.com. Please provide detailed information.
Viewers with disabilities can get assistance accessing this station's FCC Public Inspection File by contacting the station with the information listed below. Questions or concerns relating to the accessibility of the FCC's online public file system should be directed to the FCC at 888-225-5322, 888-835-5322 (TTY), or firstname.lastname@example.org.